Table 3.
B (SE) | β | P-value | |
---|---|---|---|
Mothers* | |||
GM-CSF | −0.060 (0.03) | −0.122 | 0.016 |
MMP-9 | −0.076 (0.04) | −0.124 | 0.034 |
Infants 6–10 weeks# | |||
IFN-γ | −0.088 (0.03) | −0.194 | 0.001 |
IL-1β | −0.048 (0.03) | −0.098 | 0.120 |
Children 24–28 months† | |||
IFN-γ | −0.097 (0.04) | −0.168 | 0.019 |
IL-1β | −0.110 (0.03) | −0.182 | 0.001 |
IL-2 | −0.075 (0.04) | −0.116 | 0.035 |
IL-4 | −0.060 (0.03) | −0.128 | 0.017 |
Multivariable regressions were performed separately for each inflammatory marker with significant differences after correcting for multiple comparisons, according to maternal HIV status as depicted in Fig. 1.
Abbreviations: GM-CSF, Granulocyte-macrophage colony-stimulating factor; MMP-9 metalloproteinase-9; IFN-γ, interferon-γ; IL, interleukin
covariates: clinic, smoking, alcohol exposure, age, socioeconomic status and body mass index (BMI) at 6 weeks postpartum.
covariates: clinic, maternal smoking during pregnancy maternal alcohol exposure during pregnancy, maternal socioeconomic status and maternal BMI at 6 weeks postpartum, prematurity, birth weight, exclusive breastfeeding at 6–10 weeks and infant sex.
covariates: clinic, maternal smoking during pregnancy, maternal alcohol exposure during pregnancy, prematurity, maternal socioeconomic status and maternal BMI at 6 weeks postpartum, birth weight and child sex.